Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study
Saiki, J.H.; Baker, L.H.; Stephens, R.L.; Fabian, C.J.; Kraut, E.H.; Fletcher, W.S.
Cancer Treatment Reports 66(8): 1673-1674
1982
ISSN/ISBN: 0361-5960 PMID: 7105060 Document Number: 196934
Document emailed within 1 workday
Related Documents
Buesa, J.M.; Mouridsen, H.T.; Santoro, A.; Somers, R.; Bramwell, V.; van Oosterom, A.T.; Wagener, T.; Vendrik, C.; Thomas, D. 1984: Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase Ii trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Cancer Treatment Reports 68(4): 683-684Samal, B.; Jones, S.; Brownlee, R.W.; Morrison, F.; Hoogstraten, B.; Caoili, E.; Baker, L. 1978: Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study Cancer Treatment Reports 62(1): 19-22
Yalcin, B.; Pamir, A.; Buyukcelik, A.; Utkan, G.; Akbulut, H.; Demirkazik, A.; Icli, F. 2004: High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas Experimental Oncology 26(4): 320-325
Goodwin, W.; Stephens, R.; McCracken, J.D.; Groppe, C. 1981: Therapy for advanced colorectal cancer with a combination of 5-FU and anguidine: a Southwest Oncology Group Study Cancer Treatment Reports 65(3-4): 359
Mouridsen, H.T.; Bramwell, V.H.; Lacave, J.; Metz, R.; Vendrik, C.; Hild, J.; McCreanney, J.; Sylvester, R. 1981: Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase Ii trial of the EORTC soft tissue and bone sarcoma group Cancer Treatment Reports 65(5-6): 509-511
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Wagener, D.J.; van Oosterom, A.T.; Mulder, J.H.; Somers, R.; Mouridsen, H.T.; Cortes Funes, H.; Thomas, D.; Sylvester, R. 1986: Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer Cancer Treatment Reports 70(5): 615-618
Gagliano, R.G.; Panettiere, F.J.; Haas, C.D.; Baker, L.; Hewlett, J.; Stuckey, W.J.; O'Bryan, R.M.; Bottomley, R.; Heilburn, L.K. 1981: Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. a Southwest Oncology Group study Cancer Clinical Trials 4(4): 401-405
Miller, T.P.; Jones, S.E.; Rainey, J.M. 1983: Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase Ii Study Cancer Treatment Reports 67(7-8): 739-740
Knight, W.A.; Loesch, D.M.; Leichman, L.P.; Fabian, C.; O'Bryan, R.M. 1982: Methyl-GAG in advanced colon cancer: a phase Ii trial of the Southwest Oncology Group Cancer Treatment Reports 66(12): 2099-2100
Espinosa, E.; González Barón, M.; Zamora, P.; García de Paredes, M.L.; Espinosa, J. 1993: Soft tissue sarcomas: thirteen years experience in the service of medical oncology of a general hospital Neoplasma 40(5): 333-335
Comandone, A.; Bretti, S.; Bertetto, O.; Oliva, C.; Bergnolo, P.; Bumma, C. 2000: Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas Anticancer Research 20(3b): 2077-2080
Rouëssé, J.; Tubiana-Hulin, M. 1991: Treatment of bone and soft tissue sarcomas Presse Medicale 20(27): 1249-1251
Furuse, K. 1988: Prognostic factors of bone and soft tissue sarcomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(7): 2050-2055
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Tallroth, K.; Makai, F.; Musumeci, R. 1980: Lymphography in bone and soft tissue sarcomas. Experiences from three institutions Tumori 66(6): 721-728
Henriquez, I.; Cañadell, J.; Abuchaibe, O.; Sierrasesúmaga, L.; Aguilella, L.; Calvo, F.A. 1990: Preservation of the extremity in bone and soft tissue sarcomas with multidisciplinary treatment La Chirurgia Degli Organi di Movimento 75(1 Suppl): 258-259
Hilgers, R.D.; Von Hoff, D.D.; Stephens, R.L.; Boutselis, J.G.; Rivkin, S.E. 1985: Mitoxantrone in adenocarcinoma of the endometrium: a Southwest Oncology Group Study Cancer Treatment Reports 69(11): 1329-1330
Koch, G.; Mertelsmann, R.; Stein, E.; Kastendieck, H.; Bartscherer, M. 1978: Malignant tumors of the soft tissue and the peripheral nervous system (soft tissue sarcomas). Current aspects of diagnosis and therapy Die Medizinische Welt 29(1): 31-34
Oishi, N.; Berenberg, J.; Blumenstein, B.A.; Johnson, K.; Rivkin, S.E.; Bukowski, R.M.; O'Bryan, R.M.; Stephens, R.L.; Quagliana, J.; Saiers, J.H. 1987: Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study Cancer Treatment Reports 71(12): 1307-1308